KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 107 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q4 2014. The put-call ratio across all filers is 12.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $8,450,000 | -34.3% | 112,702 | -34.0% | 2.10% | -22.2% |
| Q2 2015 | $12,858,000 | +96.8% | 170,737 | +31.0% | 2.70% | +79.8% |
| Q1 2015 | $6,535,000 | +51.9% | 130,307 | +5.0% | 1.50% | +43.7% |
| Q4 2014 | $4,303,000 | -5.6% | 124,087 | -10.8% | 1.05% | -8.5% |
| Q3 2014 | $4,557,000 | -22.2% | 139,092 | -8.9% | 1.14% | -21.9% |
| Q2 2014 | $5,858,000 | +8.1% | 152,662 | +12.0% | 1.46% | +5.2% |
| Q1 2014 | $5,419,000 | +7.9% | 136,305 | +1.4% | 1.39% | +2.4% |
| Q4 2013 | $5,022,000 | +19.3% | 134,465 | +45.6% | 1.36% | -5.6% |
| Q3 2013 | $4,210,000 | – | 92,350 | – | 1.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AlpInvest Partners B.V. | 48,087 | $1,668,000 | 4.13% |
| Versant Venture Management, LLC | 70,376 | $2,440,640,000 | 2.33% |
| Palo Alto Investors LP | 1,121,884 | $38,907,000 | 2.28% |
| Aureus Asset Management, LLC | 124,087 | $4,303,000 | 1.05% |
| PFM Health Sciences, LP | 1,085,315 | $37,639,000 | 0.88% |
| HARBOURVEST PARTNERS LLC | 39,318 | $1,364,000 | 0.72% |
| REGENTATLANTIC CAPITAL LLC | 176,454 | $6,119,425,000 | 0.52% |
| Partner Investment Management, L.P. | 24,456 | $848,000 | 0.35% |
| Old West Investment Management, LLC | 15,162 | $525,000 | 0.32% |
| Polar Capital LLP | 405,544 | $14,063,000 | 0.27% |